Breast Cancer

Latest News

Menopausal hormone therapy is associated with a higher risk of developing certain breast cancer subtypes. | Image Credit: vectorfusionart - stock.adobe.com
Hormone Therapy Use Differentially Associated With Breast Cancer Subtypes

July 16th 2025

Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with a higher risk of developing luminal-like breast cancer subtypes and other subtypes.

In women who have overweight or obesity in adulthood, the risk of breast cancer is 1.15 times higher among those who also have a history of CVD.  | Image credit: Axel Kock - stock.adobe.com
CVD and BMI Linked to Postmenopausal Breast Cancer

July 14th 2025

Data suggest trastuzumab deruxtecan and pertuzumab may represent a new first-line standard of care for metastatic, HER2-positive breast cancer. | Image credit: Axel Kock - stock.adobe.com
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer

June 2nd 2025

AJMC
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

April 4th 2025

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Watch the latest AJMC Peer Exchange on Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo